The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge. Managing a large number of acutely ill patients in a short time, whilst reducing …

Introduction Covid‐19 is linked with the development of cardio‐metabolic disorders,
including dyslipidemia, dysregulation of high‐density lipoprotein (HDL), and low‐density …

The transmissible respiratory disease COVID-19, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected millions of people worldwide since its …

The current coronavirus disease 2019 (COVID‐19) pandemic presents a global challenge
for managing acutely ill patients and complications from viral infection. Systemic …

High-density lipoproteins (HDLs) are a class of blood particles, principally involved in
mediating reverse cholesterol transport from peripheral tissue to liver. Omics approaches …

Plasma membrane cholesterol is required for proper trafficking and localization of receptors
that facilitate severe acute respiratory syndrome coronavirus 2 infection. High-density …

Background and aims To systematically address all the relevant evidence of the association
between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection. Methods We …

It is well recognized that gram positive and negative bacterial infections, tuberculosis, fungal
infections, and parasitic infections result in changes in plasma lipid levels (1–12). Of note …

Abstract Coronavirus disease 2019 (COVID-19) pandemic is affecting millions of patients
worldwide. The consequences of initial exposure to SARS-CoV-2 go beyond pulmonary …

Background. The new coronavirus pneumonia (NCP, COVID-19) outbreak began in Wuhan
in December 2019. The new coronavirus (2019 novel coronavirus (2019-nCoV)) can cause …